CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,282
-60.9%
99,356
+153.8%
0.00%
Q2 2023$46,782
+72.9%
39,1480.0%0.00%
Q1 2023$27,059
+1.8%
39,1480.0%0.00%
Q4 2022$26,581
-35.2%
39,1480.0%0.00%
Q3 2022$41,000
+51.9%
39,1480.0%0.00%
Q2 2022$27,000
-87.8%
39,148
-85.2%
0.00%
Q1 2022$222,000
-44.6%
264,684
+7.7%
0.00%
Q4 2021$401,000
-32.4%
245,6790.0%0.00%
Q3 2021$593,000
+12.3%
245,679
+22.9%
0.00%
Q2 2021$528,000
+329.3%
199,917
+714.3%
0.00%
Q1 2021$123,00024,5520.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders